Posts in tag

API


Situation stabilising at wholesaler warehouse linked to COVID-19 outbreak There have been no additional confirmed positive COVID-19 cases linked to a pharmaceutical wholesalers Victorian warehouse where there were reports of …

API says it is well placed to compete in an environment affected by COVID-19, citing the success of initiatives like Priceline’s Click and Collect API presented its 2020 half-year results …

Chemist Warehouse and Priceline are reportedly asking for “massive” rent reductions, as API warns that pharmacies could close and one industry expert says some stores are severely impacted by the …

Group reports total revenue of $4 billion, up 4.1% on the prior year, excluding PBS reforms and hepatitis C medicines API has reported earnings before interest and tax of $94 …

Pharmaceutical manufacturer ditches direct distribution model for CSO wholesalers in move driven by pharmacist feedback AstraZeneca has announced it will exit its exclusive-direct distribution arrangements and return supply of its …

Despite facing PBS reform and intense competition, API reports $25 million net profit after tax and $2 billion in revenue in its half-year results for 2019 Australian Pharmaceutical Industries (API) …

APP2019 might be over, but the pharmacy sector didn’t slow down, with a big week in industrial relations and other business matters Workers at three distribution centres for Chemist Warehouse …

Sigma’s Board has rejected the API proposal to take it over as not in the best interest of Sigma shareholders The non-binding indicative proposal from API to acquire all Sigma’s …

Sigma and NPSA’s Mark Hooper has said he hopes for a swift resolution of the API/Sigma merger, and addressed the potential for DHL to enter the CSO Mr Hooper, president …

A review initiated after losing My Chemist/Chemist Warehouse supply contract has identified over $100m per year in savings Sigma Healthcare Limited has announced a “strong outlook” after conducting a review …

API thinks it has a better chance of merging with Sigma second-time around following PBS reforms and a changed industry landscape Last Friday Australian Pharmaceutical Industries Limited (API) announced that …

Under the scheme, API shareholders would own approximately 63% of the combined entity with Sigma shareholders owning the remaining 37% Australian Pharmaceutical Industries Limited (API) has today lodged a substantial …